Reduced cytosolic acidification during exercise suggests defective glycolytic activity in skeletal muscle of patients with Becker muscular dystrophy. An in vivo 31P magnetic resonance spectroscopy study

Brain

Volumn 122, Issue 1, 1999, Pages 121-130

  Lodi, Raffaele ^a,d   Kemp, Graham J ^b   Muntoni, Francesco ^c   Thompson, Campbell H ^a   Rae, Caroline ^a   Taylor, Jacqueline ^c   Styles, Peter ^a   Taylor, Doris J ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITY OF LIVERPOOL   (United Kingdom)

^c HAMMERSMITH HOSPITAL   (United Kingdom)

^d OXFORD UNIVERSITY HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Becker muscular dystrophy; Dystrophin; Energy metabolism; Magnetic resonance spectroscopy; Skeletal muscle

Indexed keywords

ADENOSINE TRIPHOSPHATE; PROTON;

ACIDIFICATION; ADOLESCENT; ADULT; ARTICLE; BECKER MUSCULAR DYSTROPHY; CELL PH; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; EXERCISE; GLYCOLYSIS; HUMAN; MAGNET; MALE; MITOCHONDRIAL RESPIRATION; MUSCLE METABOLISM; PHOSPHORUS NUCLEAR MAGNETIC RESONANCE; PRIORITY JOURNAL; PROTON TRANSPORT; SKELETAL MUSCLE; SPECTROMETER;

ACIDS; ADENOSINE TRIPHOSPHATE; ADOLESCENT; ADULT; CHILD; CYTOSOL; ENERGY METABOLISM; EXERCISE; GLYCOLYSIS; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MITOCHONDRIA, MUSCLE; MUSCLE, SKELETAL; MUSCULAR DYSTROPHIES; OXIDATION-REDUCTION; PHOSPHORUS;

EID: 0032959413     PISSN: 00068950     EISSN: None     Source Type: Journal    
DOI: 10.1093/brain/122.1.121     Document Type: Article

References (57)

1. Archibald KC, Vignos PJ. A study of contractures in muscular dystrophy. Arch Phys Med Rehabil 1959; 40: 150-7.
2. 31P MRS) in neuromuscular disorders. [Review]. Ann Neurol 1991; 30: 90-7.
3. 31P MRS study. NMR Biomed 1996; 9: 165-72.
4. 31P-NMR. Magn Resonance Med 1984; 1: 307-15.
5. Arnold DL, Taylor DJ, Radda GK. Investigation of human mitochondrial myopathies by phosphorous magnetic resonance spectroscopy. Ann Neurol 1985; 18: 189-96.
6. 31P-NMR spectroscopy of skeletal muscle in Becker dystrophy and DMD/BMD carriers. Altered rate of phosphate transport. J Neurol Sci 1992; 109: 188-95.
7. 31P magnetic resonance spectroscopy study. Brain 1997; 120: 1699-711.
8. Bia BL, Hopkins JCA, Davis KE, Radda GK, Clarke K. Decreased myocardial nitric oxide synthase activity in Duchenne muscular dystrophy: implications for ischaemia and glucose uptake [abstract]. Circulation 1997; 96 (8 Suppl): 945.
9. Brenman JE, Chao DS, Gee SH, McGee AW, Craven SE, Santillano DR, et al. Interaction of nitric oxide synthase with the postsynaptic density protein PSD-95 and α1-syntrophin mediated by PDZ domains. Cell 1996; 84: 757-67.
10. Campbell KP. Three muscular dystrophies: loss of cytoskeleton-extracellular matrix linkage. [Review]. Cell 1995; 80: 675-9.
11. 14C]palmitic acid oxidation in Duchenne muscular dystrophy. Neurology 1985; 35: 96-7.
12. Chance B, Williams GR. Respiratory enzymes in oxidative phosphorylation. III. The steady state. J Biol Chem 1955; 217: 409-27.
13. Chao DS, Gorospe JR, Brenman JE, Rafael JA, Peters MF, Froehner SC, et al. Selective loss of sarcolemmal nitric oxide synthase in Becker muscular dystrophy. J Exp Med 1996; 184: 609-18.
14. Chi MM-Y, Hintz CS, McKee D, Felder S, Grant N, Kaiser KK, et al. Effect of Duchenne muscular dystrophy on enzymes of energy metabolism in individual muscle fibers. Metabolism 1987; 36: 761-7.
15. 87Rb NMR spectroscopic study. Magn Resonance Med 1995; 34: 673-85.
16. Cullen MJ, Jaros E. Ultrastructure of the skeletal muscle in the X-chromosome-linked dystrophic (MDX) mouse. Comparison with Duchenne muscular dystrophy. Acta Neuropathol (Berl) 1988; 77: 69-81.
17. 2+ is elevated at all ages. J Neurol Sci 1991; 103: 226-31.
18. Dunn JF, Frostick S, Brown G, Radda GK. Energy status of cells lacking dystrophin: an in vivo/in vitro study of mdx mouse skeletal muscle. Biochim Biophys Acta 1991; 1096: 115-20.
19. 31P-NMR study of muscle exercise metabolism in mdx mice: evidence for abnormal pH regulation. J Neurol Sci 1992; 113: 108-13.
20. Durnin JV, Womersley J. Body fat assessed from total body density and its estimation from skinfold thickness; measurements in 481 man and women aged from 16 to 72 years. Br J Nutr 1974; 32: 77-97.
21. Engel AG. Duchenne dystrophy. In: Engel AG, Banker BQ, editors. Myology. New York: McGraw-Hill; 1986. p. 1185-240.
22. Even PC, Decrouy A, Chinet A. Defective regulation of energy metabolism in mdx-mouse skeletal muscles. Biochem J 1994; 304: 649-54.
23. Gannoun-Zaki L, Fournier-Bidoz S, Le Cam G, Chambon C, Millasseau P, Leger JJ, et al. Down-regulation of mitochondrial mRNAs in the mdx mouse model for Duchenne muscular dystrophy. FEBS Lett 1995; 375: 268-72.
24. Glesby MJ, Rosenmann E, Nylen EG, Wrogemann K. Serum CK, calcium, magnesium, and oxidative phosphorylation in mdx mouse muscular dystrophy. Muscle Nerve 1988; 11: 852-6.
25. Hasin Y, Barry WH. Myocardial metabolic inhibition and membrane potential, contraction, potassium uptake. Am J Physiol 1984; 247: H322-9.
26. Hauser E, Hoger H, Bittner R, Widhalm K, Herkner K , Lubec G. Oxyradical damage and mitochondrial enzyme activities in the mdx mouse. Neuropediatrics 1995; 26: 260-2.
27. Hoffman EP, Brown RH Jr, Kunkel LM. Dystrophin: the protein product of the Duchenne muscular dystrophy locus. Cell 1987; 51: 919-28.
28. Jeneson JAL, Wiseman RW, Westerhoff HV, Kushmerick MJ. The signal transduction function for oxidative phosphorylation is at least second order in ADP. J Biol Chem 1996; 271: 27995-8.
29. Kahn BB, Rossetti L, Lodish HF, Charron MJ. Decreased in vivo glucose uptake but normal expression of GLUT1 and GLUT4 in skeletal muscle of diabetic rats. J Clin Invest 1991; 87: 2197-206.
30. Kemp GJ, Taylor DJ, Dunn JF, Frostick SP, Radda GK. Cellular energetics of dystrophic muscle. J Neurol Sci 1993a; 116: 201-6.
31. Kemp GJ, Taylor DJ, Radda GK. Control of phosphocreatine resynthesis during recovery from exercise in human skeletal muscle. NMR Biomed 1993b; 6: 66-72.
32. Kemp GJ, Taylor DJ, Styles P, Radda GK. The production, buffering and efflux of protons in human skeletal muscle during exercise and recovery. NMR Biomed 1993c; 6: 73-83.
33. 31P magnetic resonance spectroscopy. Magn Resonance Med 1994; 31: 248-58.
34. Kushmerick MJ. Multiple equilibria of cations with metabolites in muscle bioenergetics. Am J Physiol 1997; 272: C1739-47.
35. Letellier T, Malgat M, Mazat JP. Control of oxidative phosphorylation in rat muscle mitochondria. Implications for mitochondrial myopathies. Biochim Biophys Acta 1993; 1141: 58-64.
36. Lodi R, Kemp GJ, Iotti S, Radda GK, Barbiroli B. Influence of cytosolic pH on in vivo assessment of human muscle mitochondrial respiration by phosphorus magnetic resonance spectroscopy. Magma 1997a; 5: 165-71.
37. 31P-MR spectroscopy study in sarcoglycan deficient limb muscular dystrophy. Neuromusc Disord 1997b; 8: 505-11.
38. 31P magnetic resonance spectroscopy. Brain 1998; 121: 2119-26.
39. MacLennan P, McArdle A, Edwards RH. Acute effects of phorbol esters on the protein-synthetic rate and carbohydrate metabolism of normal and mdx mouse muscles. Biochem J 1991; 275: 477-83.
40. Newman RJ, Bore PJ, Chan L, Gadian DG, Styles P, Taylor D, et al. Nuclear magnetic resonance studies of forearm muscle in patients with Duchenne dystrophy. Br Med J 1982; 284: 1072-4.
41. Olichon-Berthe C, Gautier N, Van Obberghen E, Le Marchand-Brustel Y. Expression of the glucose transporter GLUT4 in the muscular dystrophic mdx mouse. Biochem J 1993; 291: 257-61.
42. Olson E, Vignos PJ, Woodlock J, Perry T. Oxidative phosphorylation of skeletal muscle in human muscular dystrophy. J Lab Clin Med 1968; 71: 220-31.
43. Reeve JL, McArdle A, Jackson MJ. Age-related changes in muscle calcium content in dystrophin-deficient mdx mice. Muscle Nerve 1997; 20: 357-60.
44. Ren JM, Hultman E. Regulation of phosphorylase a activity in human skeletal muscle. J Appl Physiol 1990; 69: 919-23.
45. Rezvani M, Cafarelli E, Hood DA. Performance and excitability of mdx mouse muscle at 2, 5, and 13 wk of age. J Appl Physiol 1995; 78: 961-7.
46. Samaha FJ, Davis B, Nagy B. Duchenne muscular dystrophy: adenosine triphosphate and creatine phosphate content in muscle. Neurology 1981; 31: 916-9.
47. Stedman HH, Sweeney HL, Shrager JB, Maguire HC, Panettieri RA, Petrof B, et al. The mdx mouse diaphragm reproduces the degenerative changes of Duchenne muscular dystrophy. Nature 1991; 352: 536-9.
48. 31P nuclear magnetic resonance study. Mol Biol Med 1983; 1: 77-94.
49. Taylor DJ, Kemp GJ, Thompson CH, Radda GK. Ageing: effects on oxidative function of skeletal muscle in vivo. Mol Cell Biochem 1997; 174: 321-4.
50. Tracey I. MRS and biochemical studies on animal models of human disease [D Phil thesis]. Oxford: Oxford University; 1993.
51. Veech RL, Lawson JW, Cornell NW, Krebs HA. Cytosolic phosphorylation potential. J Biol Chem 1979; 254: 6538-47.
52. Vignos PJ, Lefkowitz M. A biochemical study of certain skeletal muscle constituents in human progressive muscular dystrophy. J Clin Invest 1979; 38: 873-81.
53. Walter G, Vandenborne K, McCully KK, Leigh JS. Noninvasive measurement of phosphocreatine recovery kinetics on single human muscles. Am J Physiol 1997; 272: C525-34.
54. Wink DA, Hanbauer I, Krishna MC, DeGraff W, Gamson J, Mitchell JB. Nitric oxide protects against cellular damage and cytotoxicity from reactive oxygen species. Proc Natl Acad Sci USA 1993; 90: 9813-7.
55. Wrogemann K, Pena SD. Mitochondrial calcium overload: a general mechanism for cell necrosis in muscle diseases. Lancet 1976; 1: 672-4.
56. Young ME, Radda GK, Leighton B. Nitric oxide stimulates glucose transport and metabolism in rat skeletal muscle in vitro. Biochem J 1997; 322: 223-8.
57. Younkin D, Berman P, Sladky J, Chee C, Bank W, Chance B. 31P NMR studies in Duchenne muscular dystrophy: age-related metabolic changes. Neurology 1987: 37: 165-9.